Therapeutic efficacy of optimized eCD4-Ig proteins in SHIV-infected rhesus macaques
Saved in:
Main Authors: | M.R. Gardner (Author), M. Guttman (Author), I. Fetzer (Author), K.K. Lee (Author), M. Farzan (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2017-12-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
OP 6.8 - 00102 In vivo evolution of env in SHIV-AD8-infected rhesus macaques after AAV-eCD4-Ig therapy
by: D. O'Hagan, et al.
Published: (2022) -
Properties of eCD4-Ig relevant to reducing the viral reservior
by: M. Farzan, et al.
Published: (2017) -
Replacing daily cART with AAV-expressed eCD4-Ig
by: M. Gardner, et al.
Published: (2019) -
eCD4-Ig promotes ADCC activity of sera from HIV-1-infected patients
by: M.E. Davis-Gardner, et al.
Published: (2017) -
Treatment of SHIV-infected, ART-suppressed rhesus macaques with bispecific HIVxCD3 DART® molecules
by: Daniel M. Gorman, et al.
Published: (2019)